ATP5B is highly expressed in human epidermal growth factor receptor 2‐positive breast cancer, highly metastatic prostate cancer, gastric cancer, and glioblastoma [168, 169, 170, 171]. Here, ATP5F1B is linked to prostate carcinoma.